About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Relative Potency of Inhaled Corticosteroids | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT00292838

Relative Potency of Inhaled Corticosteroids

To investigate the validity of a clinical model to determine the relative potency of different preparations of inhaled corticosteroids used for the treatment of asthma or of eosinophilic bronchitis wi...

Lead sponsor: St. Joseph's Healthcare Hamilton•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

St. Joseph's Healthcare Hamilton

Collaborators

GlaxoSmithKline

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Sputum eosinophilia \>3%
•Adults age 18-70 years
•History of episodic wheeze, chest tightness, dyspnea or cough within the last 12 months.
•FEV1 ≥ 60% predicted
•Steroid naive or on not more than 500 µg a day of beclomethasone or equivalent.
•Able to give written informed consent

Exclusion Criteria

•1. Recent asthma or COPD exacerbation (as judged by the clinician) due to respiratory infection within the last month
•2. Relevant seasonal allergen exposure within 4 weeks or within the course of the study
•3. Treatment with prednisone or antibiotics or hospitalisation within the past 6 weeks
•4. Other respiratory diseases
•5. Women who are pregnant or unwilling to use appropriate contraception during the study
•6. Unable to withhold short-acting ß-agonist treatment for 6 hours before visit

Related studies

RECRUITINGPhase 2

A Phase IIb Trial of LQ036 in Poorly Controlled Asthma

NCT07589439 · Asthma

Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation

NCT07011394 · Diagnosis, Inflammation, and more

RECRUITINGPhase 3

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

NCT06023589 · Asthma

RECRUITINGPhase 3

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

NCT06979323 · Asthma

RECRUITINGPhase 2

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

NCT07323654 · Eosinophilic Asthma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 20, 2011Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment40

Start dateJan 2001

Last updatedJul 20, 2011

Condition

Asthma Chronic Obstructive Pulmonary Disease (COPD)

Locations shown

Firestone Institute for Respiratory Health, St. Joseph's Healthcare

Hamilton, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 20, 2011Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions